Category Ranking
98%
Total Visits
921
Avg Visit Duration
2 minutes
Citations
20
Article Abstract
Background And Aims: The human immunodeficiency virus (HIV) and its treatment are commonly associated with blood cell morphological and numerical abnormalities. As a result, routine examination of blood disorders among HIV patients is necessary to minimize related complications and improve patients' prognosis. Therefore, the aim of the current study is also to assess quantitative and qualitative blood cell disorders among high-level antiretroviral therapy (HAART)-experienced children.
Method: A cross-sectional study was conducted among 213 HIV-infected children from June to July 2021. For laboratory analysis, about 5 mL of venous blood was collected and transferred to an EDTA test tube for a complete blood cell count. Besides, the shape, size, color, distribution, cytoplasmic inclusions of red blood cells (RBCs), and structures of other major cell lines were meticulously evaluated using a stained blood smear preparation. The data were entered into EPI-Info version 3.5.3 and then transferred to SPSS version 25 for analysis. Descriptive statistics were summarized as percentages, means, and standard deviations.
Results: RBC abnormalities, such as poikilocytosis and anisocytosis, were observed in 54.4% and 26.3% of patients, respectively. Additionally, microcytosis, giant cells, and target cells were observed in 20.7%, 12.7%, and 23% of patients, respectively. In this study, the most common quantitative RBC abnormality was anemia, occurring in 35 (16.4%) of patients. Regarding white blood cell abnormalities, leukopenia and lymphopenia were detected among 12.2% and 10.3% of study participants, respectively. However, only 1.9% of the patients had a quantitative platelet disorder.
Conclusion: Various quantitative and qualitative blood disorders were observed in HAART-experienced HIV patients. Therefore, morphology examination together with full blood count may yield a speedy diagnosis, rationalized diagnostic work-up, and timely initiation of treatment for hematological complications, especially for HIV infected children.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC12179746 | PMC |
| http://dx.doi.org/10.1002/hsr2.70905 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Luminescent Electro-Spun Nanofibers Crosslinked with Boronic Esters Exhibiting Controlled Release of Carbon Dots for Detection of Wound pHs and Enhanced Antimicrobial.
Macromol Biosci
September 2025
Department of Chemistry and Biochemistry, Concordia University, Montreal, Quebec, Canada.
Timely and accurate assessment of wounds during the healing process is crucial for proper diagnosis and treatment. Conventional wound dressings lack both real-time monitoring capabilities and active therapeutic functionalities, limiting their effectiveness in dynamic wound environments. Herein, we report our proof-of-concept approach exploring the unique emission properties and antimicrobial activities of carbon nanodots (CNDs) for simultaneous detection and treatment of bacteria.
View Article and Find Full Text PDFMicrobial cell-free DNA for diagnosis of bacterial and fungal infection in the immunocompromised host - what do we know?
Curr Opin Infect Dis
August 2025
Transplant and Immunocompromised Host Infectious Diseases, Department of Medicine, Infectious Diseases Division, Massachusetts General Hospital.
Purpose Of Review: Plasma metagenomic next-generation sequencing (mNGS) enables detection of microbial cell-free deoxyribonucleic acid (mcfDNA) in blood without the need for culture or organism-specific primers. Here, we review clinical performance, methodological variability, and real-world application of plasma mNGS for infectious disease diagnosis in immunocompromised hosts (ICHs).
Recent Findings: Plasma mNGS has rapidly gained attention as a novel diagnostic tool for infections in ICHs, offering broad-range pathogen detection from a noninvasive blood sample.
Combinatorial targeting of PI3K/AKT pathway with BKM120 increases cisplatin sensitivity and apoptotic response in A549 lung cancer cells.
Cell Mol Biol (Noisy-le-grand)
September 2025
Department of Hematology and Blood Banking, School of Allied Medical Sciences, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
Despite significant advancements in the treatment of non-small cell lung cancer (NSCLC) using conventional therapeutic methods, drug resistance remains a major factor contributing to disease recurrence. In this study, we aimed to explore the potential benefits of combining PI3K inhibition with Cisplatin in the context of NSCLC-derived A549 cells. Human non-small cell lung cancer A549 cells were cultured and treated with BKM120, cisplatin, or their combination.
View Article and Find Full Text PDFAn early prediction of postprandial glycemia evolution using the MD001 algorithm: a muticentre prospective trial.
Cell Mol Biol (Noisy-le-grand)
September 2025
M-DT1, Roquefort-les Pins, France.
To date, the closed-loop system represents the best commercialized management of type 1 diabetes. However, mealtimes still require carbohydrate estimation and are often associated with postprandial hyperglycemia which may contribute to poor metabolic control and long -term complications. A multicentre, prospective, non-interventional clinical trial was designed to determine the effectiveness of a novel algorithm to predict changes in blood glucose levels two hours after a usual meal.
View Article and Find Full Text PDFConcentration and integrity index of circulating cell-free DNA as a biomarker in pediatric patients with B-ALL.
Cell Mol Biol (Noisy-le-grand)
September 2025
Doctorado en Genética Humana, Centro Universitario de Ciencias de la Salud. Universidad de Guadalajara, Jalisco, México.
The objective of this study was to evaluate the concentration and integrity index of circulating cell-free DNA (ccf-DNA) as biomarkers for the detection and monitoring of minimal residual disease (MRD) in pediatric patients with B-cell acute lymphoblastic leukemia (B-ALL). Comparison with a validated methodology for the quantification of monoclonal rearrangements of the IGH gene was made. Peripheral blood and bone marrow samples were collected from 10 pediatric patients with B-ALL at diagnosis, remission, and maintenance phases.
View Article and Find Full Text PDF